We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-1.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.6B
AUM Growth
-$295M
(-0.99%)
Cap. Flow
+$533M
Cap. Flow
% of AUM
1.8%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,681
New
221
Increased
1,693
Reduced
1,498
Closed
186
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.2M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$31.3M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$28.4M |
| 4 |
Capital Group Dividend Value ETF
CGDV
|
+$20.8M |
| 5 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$53.2M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$41.8M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$39.9M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$28.2M |
| 5 |
Vanguard Extended Market ETF
VXF
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.67% |
| 2 | Financials | 5.49% |
| 3 | Consumer Discretionary | 3.63% |
| 4 | Healthcare | 3.13% |
| 5 | Communication Services | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
3451
Agenus
AGEN
$311M
| $21K | ﹤0.01% |
13,712
-387
| -3% | -$1.11K |
|
3452
Annexon
ANNX
$873M
| $21K | ﹤0.01% |
10,700
-500
| -4% | -$1.66K |
|
3453
Gossamer Bio
GOSS
$86.8M
| $21K | ﹤0.01% |
19,300
+3,300
| +21% | +$3.81K |
|
3454
Microvision
MVIS
$111M
| $21K | ﹤0.01% |
1,139
-811
| -42% | -$16.9K |
|
|
USAS
3455
Americas Gold and Silver
USAS
$1.75B
| $21K | ﹤0.01% |
15,822
-860
| -5% | -$1.09K |
|
3456
Kopin
KOPN
$930M
| $20K | ﹤0.01% |
20,940
+996
| +5% | +$1.47K |
|
|
DC.WS
3457
DELISTED
Dakota Gold Corp Warrants
DC.WS
| $19K | ﹤0.01% |
26,008
-13,900
| -35% | -$12.4K |
|
3458
Gevo
GEVO
$391M
| $19K | ﹤0.01% |
16,353
+3,595
| +28% | +$6.02K |
|
|
INTZ
3459
Intrusion
INTZ
$15M
| $19K | ﹤0.01% |
+16,622
| New | +$27.5K |
|
3460
AtaiBeckley Inc
ATAI
$2.68B
| $18K | ﹤0.01% |
13,445
+425
| +3% | +$715 |
|
3461
Cue Biopharma
CUE
$128M
| $18K | ﹤0.01% |
667
| – | – |
|
|
GAN
3462
DELISTED
GAN Ltd
GAN
| $18K | ﹤0.01% |
10,240
| – | – |
|
3463
Paramount Gold Nevada
PZG
$130M
| $18K | ﹤0.01% |
49,089
-1,538
| -3% | -$568 |
|
3464
Aware
AWRE
$26M
| $17K | ﹤0.01% |
10,656
| – | – |
|
3465
Compugen
CGEN
$236M
| $17K | ﹤0.01% |
11,525
| – | – |
|
|
NNDM
3466
Nano Dimension
NNDM
$343M
| $17K | ﹤0.01% |
+10,671
| New | +$24.2K |
|
|
PVL
3467
Permianville Royalty Trust
PVL
$57.8M
| $17K | ﹤0.01% |
+10,558
| New | +$15.7K |
|
|
SGMO
3468
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $17K | ﹤0.01% |
25,790
| – | – |
|
3469
Lucid Diagnostics
LUCD
$188M
| $15K | ﹤0.01% |
+10,000
| New | +$12K |
|
|
PLG
3470
Platinum Group Metals
PLG
$196M
| $15K | ﹤0.01% |
+11,880
| New | +$15.3K |
|
3471
Purple Innovation
PRPL
$28.4M
| $15K | ﹤0.01% |
797
-1
| -0.1% | -$23 |
|
|
ASRT
3472
DELISTED
Assertio
ASRT
| $14K | ﹤0.01% |
1,336
-9
| -0.7% | -$107 |
|
|
CGC
3473
Canopy Growth
CGC
$431M
| $14K | ﹤0.01% |
+15,421
| New | +$27.1K |
|
3474
Lightwave Logic
LWLG
$1.23B
| $13K | ﹤0.01% |
12,961
| – | – |
|
|
RJET
3475
Republic Airways Holdings
RJET
$962M
| $13K | ﹤0.01% |
1,066
| – | – |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Cambridge Investment Research Advisors held 3,681 positions worth $29.6B, down 0.99% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q1 2025 filing shows 221 new, 1,693 increased, 1,498 reduced and 186 closed positions. Its largest new stake was Hartford Large Cap Growth ETF: 374,858 shares worth $7.82M. The largest sale was iShares 0-3 Month Treasury Bond ETF, an estimated $53.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q1 2025 buy was Hartford Large Cap Growth ETF: 374,858 shares worth $7.82M.
- Cambridge Investment Research Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $39.2M increase.
- Cambridge Investment Research Advisors's biggest Q1 2025 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $53.2M.
- Cambridge Investment Research Advisors fully exited JPMorgan BetaBuilders US Mid Cap Equity ETF in Q1 2025, selling an estimated $5.47M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $29.6B portfolio in Q1 2025.
- Cambridge Investment Research Advisors opened 221 new positions and closed 186 in Q1 2025.
- Cambridge Investment Research Advisors's portfolio value fell 0.99% quarter-over-quarter to $29.6B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.